Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R

Anticancer potential of curcumin: preclinical and clinical studies.

Bharat B. Aggarwal, Anushree Kumar, Alok C. Bharti · PubMed · 2003 · 2.6K citations

Chemoprevention Strategy, Medicine, Pharmacology +12

Phase I Clinical Trial of Oral Curcumin

Ricky A. Sharma, Stephanie A. Euden, Sharon L. Platton et al. · Clinical Cancer Research · 2004 · 1.2K citations · Full text

Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.

Ricky A. Sharma, Heather R. McLelland, K A Hill et al. · PubMed · 2001 · 829 citations

Oncology, Chemoprevention Strategy, Gastrointestinal Oncology +14

Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors

Toshiyasu Taniguchi, Marc Tischkowitz, Najim Ameziane et al. · Nature Medicine · 2003 · 540 citations · Full text

Tumor Biology, Oncology, Medicine +9

Consumption of the Putative Chemopreventive Agent Curcumin by Cancer Patients: Assessment of Curcumin Levels in the Colorectum and their Pharmacodynamic Consequences

Giuseppe Garcea, David P. Berry, Donald J. L. Jones et al. · Cancer Epidemiology Biomarkers & Prevention · 2005 · 484 citations · Full text

Chemoprevention Strategy, Pathology, Pharmacotherapy +16